Reuters logo
BRIEF-Elan says proposal by Royalty Pharma remains an indication of interest
March 6, 2013 / 2:41 PM / 5 years ago

BRIEF-Elan says proposal by Royalty Pharma remains an indication of interest

LONDON, March 6 (Reuters) - Elan Corporation PLC : * Proposal” by royalty pharma remains an indication of interest, is highly

conditional * The ”proposal“ by royalty pharma remains an indication of interest * Any credible proposal” which may be made by royalty pharma or any other party

will be considered * Source Text :

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below